Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2006]

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Immunotherapy combined with targeted therapy for colorectal cancer yields promising outcomes for patients

Immunotherapy combined with targeted therapy for colorectal cancer yields promising outcomes for patients

Immunotherapy with two novel drugs shows activity in colorectal cancer

Immunotherapy with two novel drugs shows activity in colorectal cancer

FDA grants accelerated approval to tucatinib with trastuzumab for colorectal cancer

FDA grants accelerated approval to tucatinib with trastuzumab for colorectal cancer

ASCO GI: Trifluridine/tipiracil plus bevacizumab improves OS for third line mCRC

ASCO GI: Trifluridine/tipiracil plus bevacizumab improves OS for third line mCRC

Neoadjuvant immunotherapy leads to low recurrence in localised mismatch repair–deficient colorectal cancer

Neoadjuvant immunotherapy leads to low recurrence in localised mismatch repair–deficient colorectal cancer

AI improves colorectal cancer screening in Lynch syndrome

AI improves colorectal cancer screening in Lynch syndrome

Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk...

Discovery could lead to new drugs to block protein that fuels bowel cancer

Discovery could lead to new drugs to block protein that fuels bowel cancer

More from ecancer